Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications
出版年份 2019 全文链接
标题
Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-03-05
DOI
10.3389/fphar.2019.00208
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Characterization of human ATP-binding cassette protein subfamily D reconstituted into proteoliposomes
- (2018) Takumi Okamoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- BCRP/ABCG2 and high-alert medications: Biochemical, pharmacokinetic, pharmacogenetic, and clinical implications
- (2018) Daiki Hira et al. BIOCHEMICAL PHARMACOLOGY
- Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In vitro and in vivo
- (2018) Guan-Nan Zhang et al. CANCER LETTERS
- Structural basis of small-molecule inhibition of human multidrug transporter ABCG2
- (2018) Scott M. Jackson et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structural basis of small-molecule inhibition of human multidrug transporter ABCG2
- (2018) Scott M. Jackson et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Identification of ABCG2 as an Exporter of Uremic Toxin Indoxyl Sulfate in Mice and as a Crucial Factor Influencing CKD Progression
- (2018) T. Takada et al. Scientific Reports
- Polymorphisms of the multidrug pump ABCG2: a systematic review of their effect on protein expression, function and drug pharmacokinetics
- (2018) Niall Heyes et al. DRUG METABOLISM AND DISPOSITION
- Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance
- (2018) Ning Ji et al. BIOCHEMICAL PHARMACOLOGY
- A Novel Synthetic Dihydroindeno[1,2-b] Indole Derivative (LS-2-3j) Reverses ABCB1- and ABCG2-Mediated Multidrug Resistance in Cancer Cells
- (2018) Chao Guo et al. MOLECULES
- VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters
- (2018) Ning Ji et al. Frontiers in Pharmacology
- Novel chalcone and flavone derivatives as selective and dual inhibitors of the transport proteins ABCB1 and ABCG2
- (2018) Katja Silbermann et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Alpha-Mangostin Reverses Multidrug Resistance by Attenuating the Function of the Multidrug Resistance-Linked ABCG2 Transporter
- (2017) Chung-Pu Wu et al. MOLECULAR PHARMACEUTICS
- Structure of the human multidrug transporter ABCG2
- (2017) Nicholas M. I. Taylor et al. NATURE
- Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase
- (2017) Nael Alakel et al. OncoTargets and Therapy
- ABCG2-overexpressing H460/MX20 cell xenografts in athymic nude mice maintained original biochemical and cytological characteristics
- (2017) Wei Zhang et al. Scientific Reports
- The structure of the human ABC transporter ABCG2 reveals a novel mechanism for drug extrusion
- (2017) Narakorn Khunweeraphong et al. Scientific Reports
- Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol
- (2016) Kazuo Tamura et al. International Journal of Clinical Oncology
- ABCG2/BCRP: Specific and Nonspecific Modulators
- (2016) Diana Peña-Solórzano et al. MEDICINAL RESEARCH REVIEWS
- Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters
- (2016) Yun-Kai Zhang et al. Scientific Reports
- Identification of Febuxostat as a New Strong ABCG2 Inhibitor: Potential Applications and Risks in Clinical Situations
- (2016) Hiroshi Miyata et al. Frontiers in Pharmacology
- Virtual Screening of DrugBank Reveals Two Drugs as New BCRP Inhibitors
- (2016) Floriane Montanari et al. SLAS Discovery
- Halogenated hydrocarbon solvent-related cholangiocarcinoma risk: biliary excretion of glutathione conjugates of 1,2-dichloropropane evidenced by untargeted metabolomics analysis
- (2016) Yu Toyoda et al. Scientific Reports
- FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk
- (2015) M. Spina et al. ANNALS OF ONCOLOGY
- Prediction of Drug Transfer into Milk Considering Breast Cancer Resistance Protein (BCRP)-Mediated Transport
- (2015) Naoki Ito et al. PHARMACEUTICAL RESEARCH
- Novel dysfunctional variant inABCG2as a cause of severe tophaceous gout: biochemical, molecular genetics and functional analysis
- (2015) Blanka Stiburkova et al. RHEUMATOLOGY
- Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update
- (2014) Qingcheng Mao et al. AAPS Journal
- Pharmacophore Modeling of Nilotinib as an Inhibitor of ATP-Binding Cassette Drug Transporters and BCR-ABL Kinase Using a Three-Dimensional Quantitative Structure–Activity Relationship Approach
- (2014) Suneet Shukla et al. MOLECULAR PHARMACEUTICS
- Assessment of ABCG2-mediated transport of xenobiotics across the blood–milk barrier of dairy animals using a new MDCKII in vitro model
- (2013) Louise Wassermann et al. ARCHIVES OF TOXICOLOGY
- Cobicistat: A New Boost for the Treatment of Human Immunodeficiency Virus Infection
- (2013) Bhavik M. Shah et al. PHARMACOTHERAPY
- Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP
- (2012) Hiroyuki Kusuhara et al. BRITISH JOURNAL OF PHARMACOLOGY
- Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models
- (2012) Amit K. Tiwari et al. CANCER LETTERS
- Synthesis and Quantitative Structure-Activity Relationships of Selective BCRP Inhibitors
- (2012) Federico Marighetti et al. ChemMedChem
- ABCG2 functions as a general phytoestrogen sulfate transporter in vivo
- (2012) Koen van de Wetering et al. FASEB JOURNAL
- Decreased extra-renal urate excretion is a common cause of hyperuricemia
- (2012) Kimiyoshi Ichida et al. Nature Communications
- Drug Transporters and Imatinib Treatment: Implications for Clinical Practice
- (2010) K. Eechoute et al. CLINICAL CANCER RESEARCH
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
- (2009) J E Keskitalo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout
- (2009) O. M. Woodward et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population
- (2009) H. Matsuo et al. Science Translational Medicine
- Ins and outs of the ABCG2 multidrug transporter: An update on in vitro functional assays
- (2008) Csilla Hegedűs et al. ADVANCED DRUG DELIVERY REVIEWS
- QSAR analysis and molecular modeling of ABCG2-specific inhibitors
- (2008) E. Nicolle et al. ADVANCED DRUG DELIVERY REVIEWS
- Physiological and pharmacological roles of ABCG2 (BCRP): Recent findings in Abcg2 knockout mice
- (2008) Maria L.H. Vlaming et al. ADVANCED DRUG DELIVERY REVIEWS
- ABCG2: A perspective
- (2008) Robert W. Robey et al. ADVANCED DRUG DELIVERY REVIEWS
- Membrane reconstitution of ABC transporters and assays of translocator function
- (2008) Eric R Geertsma et al. Nature Protocols
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now